MAPK3 and lung cancer: For example, miR-483–5p, previously identified as being abnormally expressed in hepatocellular carcinoma and rectal cancer[36,37], exerts its effect by directly targeting the ERK1 pathway [33], and was recently shown to be important in lung cancer cell proliferation and senescence[38].